Literature DB >> 30160050

Quantitative chest computerized tomography and FEV1 equally identify pulmonary exacerbation risk in children with cystic fibrosis.

Don B Sanders1, Zhanhai Li2, Katelyn Parker-McGill3, Philip Farrell4, Alan S Brody5.   

Abstract

BACKGROUND: Chest computerized tomography (CT) scores are associated with the frequency of future pulmonary exacerbations in people with cystic fibrosis (CF). However, cut-off values to identify children with mild lung disease with different risks for frequent future pulmonary exacerbations have not been identified.
METHODS: Chest CT scans were assessed using the Brody score for participants of the Pulmozyme Early Intervention Trial (PEIT) and Wisconsin Randomized Clinical Trial of CF Newborn Screening (WI RCT). We determined the area under the receiver operating characteristic (ROC) curve for Brody scores and forced expiratory volume in 1 s (FEV1 ) to compare with the frequency of pulmonary exacerbations up to 10 years later.
RESULTS: There were 60 participants in the PEIT with mean (SD) age 10.6 (1.7) years at the time of the CT and 81 participants in the WI RCT with mean age 11.5 (3.0) years. The Brody score cut-off that best identified children at-risk for ≥0.3 annual pulmonary exacerbations was 3.6 in the PEIT and 2.1 in the WI RCT. There were no statistical differences between ROC curves for the Brody CT score and FEV1 % predicted in either study (P ≥ 0.4).
CONCLUSIONS: CT score cut-off values that identify children with CF with mild lung disease at different risks for frequent pulmonary exacerbations over an extended follow up period are similar in separate cohorts. Brody scores and FEV1 % predicted have similar abilities to identify these children, suggesting that FEV1 % predicted alone may be adequate for predicting future frequency of pulmonary exacerbations.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Brody scores; FEV1; bronchiectasis

Mesh:

Year:  2018        PMID: 30160050      PMCID: PMC7059197          DOI: 10.1002/ppul.24144

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  42 in total

Review 1.  Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis.

Authors:  James D Chalmers; Aran Singanayagam; Ahsan R Akram; Pallavi Mandal; Philip M Short; Gourab Choudhury; Victoria Wood; Adam T Hill
Journal:  Thorax       Date:  2010-08-20       Impact factor: 9.139

2.  PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis.

Authors:  Tim Rosenow; Merel C J Oudraad; Conor P Murray; Lidija Turkovic; Wieying Kuo; Marleen de Bruijne; Sarath C Ranganathan; Harm A W M Tiddens; Stephen M Stick
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

3.  Disease-specific reference equations for lung function in patients with cystic fibrosis.

Authors:  Michal Kulich; Margaret Rosenfeld; Jonathan Campbell; Richard Kronmal; Ron L Gibson; Christopher H Goss; Bonnie Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

Review 4.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

5.  Improving rate of decline of FEV1 in young adults with cystic fibrosis.

Authors:  C Que; P Cullinan; D Geddes
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

6.  Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.

Authors:  Donald R VanDevanter; Jeffrey S Wagener; David J Pasta; Eric Elkin; Joan R Jacobs; Wayne J Morgan; Michael W Konstan
Journal:  Pediatr Pulmonol       Date:  2010-08-17

7.  Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Authors:  Philip M Farrell; Jannette Collins; Lynn S Broderick; Michael J Rock; Zhanhai Li; Michael R Kosorok; Anita Laxova; William M Gershan; Alan S Brody
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

8.  Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.

Authors:  Carla-Federica Bortoluzzi; Sonia Volpi; Ciro D'Orazio; Harm A W M Tiddens; Martine Loeve; Gloria Tridello; Baroukh M Assael
Journal:  J Cyst Fibros       Date:  2014-04-13       Impact factor: 5.482

9.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Authors:  Emily A Knapp; Aliza K Fink; Christopher H Goss; Ase Sewall; Josh Ostrenga; Christopher Dowd; Alexander Elbert; Kristofer M Petren; Bruce C Marshall
Journal:  Ann Am Thorac Soc       Date:  2016-07

10.  Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.

Authors:  Joseph F Levy; Marjorie A Rosenberg; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2016-10-14
View more
  1 in total

1.  Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

Authors:  Christina B Barreda; Philip M Farrell; Anita Laxova; Jens C Eickhoff; Andrew T Braun; Ryan J Coller; Michael J Rock
Journal:  J Cyst Fibros       Date:  2020-06-13       Impact factor: 5.482

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.